We compared the efficacy of immediate coronary angioplasty after acute myocardial infarction with that of elective angioplasty at 7 to 10 days in patients treated initially with intravenous tissue plasminogen activator. The plasminogen activator (150 mg) was administered 2.95 +/- 1.1 hours after the onset of symptoms, to 386 patients with acute myocardial infarction. Ninety minutes later, patency of the coronary artery serving the area of the infarct was demonstrated by coronary angiography in 288 patients (75 percent). Bleeding problems were frequently encountered, as evidenced by an average drop in hematocrit of 11.7 +/- 6.5 points from base line to nadir and by a need for transfusion not related to bypass surgery in 70 patients (18 percent). After successful thrombolysis, 197 patients with a patent but severely stenotic vessel suitable for angioplasty were randomly assigned to immediate angioplasty (n = 99) or, if indicated 7 to 10 days after infarction, to deferred (elective) angioplasty (n = 98). The incidence of reocclusion was similar in the two groups: 11 percent in the group assigned to immediate angioplasty and 13 percent in the group assigned to elective angioplasty. Neither group had a significant improvement in global left ventricular function, and regional wall motion in the infarct zone improved to a similar extent in the two groups. In the elective-angioplasty group, the rate of crossover to emergency angioplasty for recurrent ischemia was 16 percent (whereas 5 percent of the immediate-angioplasty group required emergency repeated angioplasty; P = 0.01). In 14 percent of the patients in the elective group, the stenosis was substantially reduced by the time of the seven-day follow-up angiography, obviating the need for angioplasty. We conclude that in patients with initially successful thrombolysis and suitable coronary-artery anatomy, immediate angioplasty offers no clear advantage over delayed elective angioplasty.
This article has been cited by other articles:
Dudek, D., Rakowski, T., Dziewierz, A., Kleczynski, P.
(2008). PCI after lytic therapy: when and how?. Eur Heart J Suppl
10: J15-J20
[Abstract][Full Text]
Testa, L., van Gaal, W.J., Biondi-Zoccai, G.G.L., Abbate, A., Agostoni, P., Bhindi, R., Banning, A.P.
(2008). Repeat thrombolysis or conservative therapy vs. rescue percutaneous coronary intervention for failed thrombolysis: systematic review and meta-analysis. QJM
101: 387-395
[Abstract][Full Text]
Brown, M. L., Sundt, T. M. III, Gersh, B. J.
(2008). Indications for Revascularization. Card Surg Adult
3: 551-572
[Full Text]
George, I., Oz, M. C.
(2008). Myocardial Revascularization after Acute Myocardial Infarction. Card Surg Adult
3: 669-696
[Full Text]
Lin, G. A., Dudley, R. A., Redberg, R. F.
(2007). Cardiologists' Use of Percutaneous Coronary Interventions for Stable Coronary Artery Disease. Arch Intern Med
167: 1604-1609
[Abstract][Full Text]
Kiernan, T. J., Ting, H. H., Gersh, B. J.
(2007). Facilitated percutaneous coronary intervention: current concepts, promises, and pitfalls. Eur Heart J
28: 1545-1553
[Abstract][Full Text]
Gibson, C. M., Murphy, S. A., Montalescot, G., Morrow, D. A., Ardissino, D., Cohen, M., Gulba, D. C., Kracoff, O. H., Lewis, B. S., Roguin, N., Antman, E. M., Braunwald, E., for the ExTRACT-TIMI 25 Investigators,
(2007). Percutaneous Coronary Intervention in Patients Receiving Enoxaparin or Unfractionated Heparin After Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction in the ExTRACT-TIMI 25 Trial. J Am Coll Cardiol
49: 2238-2246
[Abstract][Full Text]
Rispler, S., Keidar, Z., Ghersin, E., Roguin, A., Soil, A., Dragu, R., Litmanovich, D., Frenkel, A., Aronson, D., Engel, A., Beyar, R., Israel, O.
(2007). Integrated Single-Photon Emission Computed Tomography and Computed Tomography Coronary Angiography for the Assessment of Hemodynamically Significant Coronary Artery Lesions. J Am Coll Cardiol
49: 1059-1067
[Abstract][Full Text]
Borden, W. B., Faxon, D. P.
(2006). Facilitated Percutaneous Coronary Intervention. J Am Coll Cardiol
48: 1120-1128
[Abstract][Full Text]
(2005). Part 8: Stabilization of the Patient With Acute Coronary Syndromes. Circulation
112: IV-89-IV-110
[Full Text]
Cantor, W. J., Brunet, F., Ziegler, C. P., Kiss, A., Morrison, L. J.
(2005). Immediate angioplasty after thrombolysis: a systematic review. CMAJ
173: 1473-1481
[Abstract][Full Text]
Huber, K., Caterina, R. D., Kristensen, S. D., Verheugt, F. W.A., Montalescot, G., Maestro, L. B., Werf, F. V. d., for the Task Force on Pre-hospital Reperfusion The,
(2005). Pre-hospital reperfusion therapy: a strategy to improve therapeutic outcome in patients with ST-elevation myocardial infarction. Eur Heart J
26: 2063-2074
[Full Text]
Beygui, F., Montalescot, G.
(2005). The use of GP IIb/IIIa inhibitors into new perspectives: pre-catheterization laboratory administration. Eur Heart J Suppl
7: I10-I14
[Abstract][Full Text]
Namdar, M., Hany, T. F., Koepfli, P., Siegrist, P. T., Burger, C., Wyss, C. A., Luscher, T. F., von Schulthess, G. K., Kaufmann, P. A.
(2005). Integrated PET/CT for the Assessment of Coronary Artery Disease: A Feasibility Study. JNM
46: 930-935
[Abstract][Full Text]
Gersh, B. J., Stone, G. W., White, H. D., Holmes, D. R. Jr
(2005). Pharmacological Facilitation of Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: Is the Slope of the Curve the Shape of the Future?. JAMA
293: 979-986
[Abstract][Full Text]
de Jaegere, P. P, Serruys, P. W, Simoons, M. L
(2004). Should all patients with an acute myocardial infarction be referred for direct PTCA?. Heart
90: 1352-1357
[Full Text]
Writing Committee Members, , Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., Mullany, C. J., Ornato, J. P., Pearle, D. L., Sloan, M. A., Smith, S. C. Jr, Task Force Members, , Antman, E. M., Smith, S. C. Jr, Alpert, J. S., Anderson, J. L., Faxon, D. P., Fuster, V., Gibbons, R. J., Gregoratos, G., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Ornato, J. P.
(2004). ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction--executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) . J Am Coll Cardiol
44: 671-719
[Full Text]
Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., Mullany, C. J., Ornato, J. P., Pearle, D. L., Sloan, M. A., Smith, S. C. Jr, Antman, E. M., Smith, S. C. Jr, Alpert, J. S., Anderson, J. L., Faxon, D. P., Fuster, V., Gibbons, R. J., Gregoratos, G., Halperin, J. L., Hiratzka, L. F., Hunt, S. A., Jacobs, A. K., Ornato, J. P.
(2004). ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation
110: 588-636
[Full Text]
Montalescot, G, Andersen, H R, Antoniucci, D, Betriu, A, de Boer, M J, Grip, L, Neumann, F J, Rothman, M T
(2004). Recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction. Heart
90: e37-e37
[Abstract][Full Text]
O'Neill, W. W., Dixon, S. R.
(2004). The year in interventional cardiology. J Am Coll Cardiol
43: 875-890
[Full Text]
Sakamoto, T., Ogawa, H., Takazoe, K., Yoshimura, M., Shimomura, H., Moriyama, Y., Arai, H., Okajima, K.
(2003). Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase: Comparison with unfractionated heparin. J Am Coll Cardiol
42: 1389-1394
[Abstract][Full Text]
Dalby, M., Bouzamondo, A., Lechat, P., Montalescot, G.
(2003). Transfer for Primary Angioplasty Versus Immediate Thrombolysis in Acute Myocardial Infarction: A Meta-Analysis. Circulation
108: 1809-1814
[Abstract][Full Text]
Weintraub, W. S., Sadanandan, S.
(2003). Percutaneous Coronary Intervention in Stable Patients After Acute Myocardial Infarction. Circulation
108: 1292-1294
[Full Text]
Zeymer, U., Uebis, R., Vogt, A., Glunz, H.-G., Vohringer, H.-F., Harmjanz, D., Neuhaus, K.-L.
(2003). Randomized Comparison of Percutaneous Transluminal Coronary Angioplasty and Medical Therapy in Stable Survivors of Acute Myocardial Infarction With Single Vessel Disease: A Study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte. Circulation
108: 1324-1328
[Abstract][Full Text]
McKay, R. G.
(2003). Evolving strategies in the treatment of acute myocardial infarction in the community hospital setting. J Am Coll Cardiol
42: 642-645
[Full Text]
Dauerman, H. L., Sobel, B. E.
(2003). Synergistic treatment of ST-segmentelevation myocardial infarction with pharmacoinvasive recanalization. J Am Coll Cardiol
42: 646-651
[Abstract][Full Text]
Gibson, C. M., Karha, J., Murphy, S. A., James, D., Morrow, D. A., Cannon, C. P., Giugliano, R. P., Antman, E. M., Braunwald, E., TIMI Study Group,
(2003). Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials. J Am Coll Cardiol
42: 7-16
[Abstract][Full Text]
O'Neill, W. W.
(2003). "Watchful waiting"after thrombolysis: It's time for a re-evaluation. J Am Coll Cardiol
42: 17-19
[Full Text]
Gabriel Steg, P., Iung, B., Feldman, L. J, Maggioni, A. P, Keil, U., Deckers, J., Cokkinos, D., Fox, K. A.A, for the ENACT investigators,
(2003). Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT. Eur Heart J
24: 613-622
[Abstract][Full Text]
The Task Force on the Management of Acute Myocardi, , Van de Werf, F., Ardissino, D., Betriu, A., Cokkinos, D. V., Falk, E., Fox, K. A.A., Julian, D., Lengyel, M., Neumann, F.-J., Ruzyllo, W., Thygesen, C., Underwood, S. R., Vahanian, A., Verheugt, F. W.A., Wijns, W.
(2003). Management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J
24: 28-66
[Full Text]
Sundt, T. M. III, Gersh, B. J., Smith, H. C.
(2003). Indications for Coronary Revascularization. Card Surg Adult
2: 541-559
[Full Text]
Lee, D. C., Ting, W., Oz, M. C.
(2003). Myocardial Revascularization after Acute Myocardial Infarction. Card Surg Adult
2: 639-658
[Full Text]
Ronner, E., van Domburg, R.T., van den Brand, M.J.B.M., de Feyter, P.J., Foley, D.P., van der Giessen, W.J., Serruys, P.W., Simoons, M.L.
(2002). Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies. A single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction. Eur Heart J
23: 1529-1537
[Abstract][Full Text]
Grines, C. L., Westerhausen, D. R. Jr, Grines, L. L., Hanlon, J. T., Logemann, T. L., Niemela, M., Weaver, W. D., Graham, M., Boura, J., O'Neill, W. W., Balestrini, C., Air PAMI Study Group,
(2002). A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: The air primary angioplasty in myocardial infarction study. J Am Coll Cardiol
39: 1713-1719
[Abstract][Full Text]
Kerensky, R. A., Wade, M., Deedwania, P., Boden, W. E., Pepine, C. J., Veterans Affairs Non-Q-Wave Infarction Strategies,
(2002). Revisiting the culprit lesion in non-Q-wave myocardial infarction: Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol
39: 1456-1463
[Abstract][Full Text]
Lancellotti, P, Benoit, T, Rigo, P, Pierard, L A
(2001). Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction. Heart
86: 510-515
[Abstract][Full Text]
Cannon, C. P.
(2001). Importance of TIMI 3 Flow. Circulation
104: 624-626
[Full Text]
Loubeyre, C, Lefevre, T, Louvard, Y, Dumas, P, Piechaud, J.-F, Lanore, J.-J, Angellier, J.-F, Le Tarnec, J.-Y, Karrillon, G, Margenet, A, Pouges, C, Morice, M.-C
(2001). Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J
22: 1128-1135
[Abstract]
Heggunje, P.S, Wade, M.J, O'Rourke, R.A, Kleiger, R.E, Deedwania, P.C, Lavori, P.W, Boden, W.E, Veterans Affairs Non-Q-Wave Infarction Strategies,
(2000). Early invasive versus ischaemia-guided strategies in the management of non-Q wave myocardial infarction patients with and without prior myocardial infarction. Results of Veterans Affairs Non-Q Wave Infarction Strategies In Hospital (VANQWISH) trial. Eur Heart J
21: 2014-2025
[Abstract]
Herrmann, H. C., Moliterno, D. J., Ohman, E. M., Stebbins, A. L., Bode, C., Betriu, A., Forycki, F., Miklin, J. S., Bachinsky, W. B., Lincoff, A. M., Califf, R. M., Topol, E. J.
(2000). Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: Results from the SPEED (GUSTO-4 Pilot) trial. J Am Coll Cardiol
36: 1489-1496
[Abstract][Full Text]
Gibson, C. M.
(2000). A union in reperfusion:: The concept of facilitated percutaneous coronary intervention. J Am Coll Cardiol
36: 1497-1499
[Full Text]
Mortensen, O S, Madsen, J K, Haghfelt, T, Grande, P, Saunamäki, K, Haunsø, S, Hjelms, E, Arendrup, H, study group, t. D.
(2000). Health related quality of life after conservative or invasive treatment of inducible postinfarction ischaemia. Heart
84: 535-540
[Abstract][Full Text]
Brass, L. M., Lichtman, J. H., Wang, Y., Gurwitz, J. H., Radford, M. J., Krumholz, H. M.
(2000). Intracranial Hemorrhage Associated With Thrombolytic Therapy for Elderly Patients With Acute Myocardial Infarction : Results From the Cooperative Cardiovascular Project. Stroke
31: 1802-1811
[Abstract][Full Text]
Goldman, L. E., Eisenberg, M. J.
(2000). Identification and Management of Patients with Failed Thrombolysis after Acute Myocardial Infarction. ANN INTERN MED
132: 556-565
[Abstract][Full Text]
Rogers, W. J., Canto, J. G., Barron, H. V., Boscarino, J. A., Shoultz, D. A., Every, N. R., for the Investigators in the National Registry of,
(2000). Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. J Am Coll Cardiol
35: 371-379
[Abstract][Full Text]
Rabah, M., Mason, D., Muller, D. W. M., Hundley, R., Kugelmass, A. D., Weiner, B., Cannon, L., O'Neill, W. W., Safian, R. D.
(1999). Heparin after percutaneous intervention (HAPI): a prospective multicenter randomized trial of three heparin regimens after successful coronary intervention. J Am Coll Cardiol
34: 461-467
[Abstract][Full Text]
Gibson, C. M.
(1999). Primary Angioplasty Compared with Thrombolysis: New Issues in the Era of Glycoprotein IIb/IIIa Inhibition and Intracoronary Stenting. ANN INTERN MED
130: 841-847
[Abstract][Full Text]
Scanlon, P. J., Faxon, D. P., Audet, A.-M., Carabello, B., Dehmer, G. J., Eagle, K. A., Legako, R. D., Leon, D. F., Murray, J. A., Nissen, S. E., Pepine, C. J., Watson, R. M., Ritchie, J. L., Gibbons, R. J., Cheitlin, M. D., Eagle, K. A., Gardner, T. J., Garson, A. Jr, Russell, R. O. Jr, Ryan, T. J., Smith, S. C. Jr
(1999). ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol
33: 1756-1824
[Full Text]
Topol, E. J., Serruys, P. W.
(1998). Frontiers in Interventional Cardiology. Circulation
98: 1802-1820
[Full Text]
Christenson, R. H., Azzazy, H. M. E.
(1998). Biochemical markers of the acute coronary syndromes. Clin. Chem.
44: 1855-1864
[Abstract][Full Text]
Boden, W. E., O'Rourke, R. A., Crawford, M. H., Blaustein, A. S., Deedwania, P. C., Zoble, R. G., Wexler, L. F., Kleiger, R. E., Pepine, C. J., Ferry, D. R., Chow, B. K., Lavori, P. W., The Veterans Affairs Non-Q-Wave Infarction Strateg,
(1998). Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy. NEJM
338: 1785-1792
[Abstract][Full Text]
White, H. D., Van de Werf, F. J. J.
(1998). Thrombolysis for Acute Myocardial Infarction. Circulation
97: 1632-1646
[Abstract][Full Text]
White, R. L
(1998). Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update. Asian Cardiovasc. Thorac. Ann.
6: 03-10
[Abstract][Full Text]
Topol, E. J.
(1998). Toward a New Frontier in Myocardial Reperfusion Therapy : Emerging Platelet Preeminence. Circulation
97: 211-218
[Full Text]
Christenson, R. H., Ohman, E. M., Topol, E. J., Peck, S., Newby, L. K., Duh, S.-H., Kereiakes, D. J., Worley, S. J., Alosozana, G. L., Wall, T. C., Califf, R. M., 7 Study Group ;, R. M.
(1997). Assessment of Coronary Reperfusion After Thrombolysis With a Model Combining Myoglobin, Creatine Kinase–MB, and Clinical Variables. Circulation
96: 1776-1782
[Abstract][Full Text]
Pilote, L., Miller, D. P., Califf, R. M., Rao, J. S., Weaver, W. D., Topol, E. J.
(1996). Determinants of the Use of Coronary Angiography and Revascularization after Thrombolysis for Acute Myocardial Infarction. NEJM
335: 1198-1205
[Abstract][Full Text]
White, H. D., Barbash, G. I., Califf, R. M., Simes, R. J., Granger, C. B., Weaver, W. D., Kleiman, N. S., Aylward, P. E., Gore, J. M., Vahanian, A., Lee, K. L., Ross, A. M., Topol, E. J.
(1996). Age and Outcome With Contemporary Thrombolytic Therapy: Results From the GUSTO-I Trial. Circulation
94: 1826-1833
[Abstract][Full Text]
Runge, M. S., Harker, L. A., Bode, C., Ruef, J., Kelly, A. B., Marzec, U. M., Allen, E., Caban, R., Shaw, S.-Y., Haber, E., Hanson, S. R.
(1996). Enhanced Thrombolytic and Antithrombotic Potency of a Fibrin-Targeted Plasminogen Activator in Baboons. Circulation
94: 1412-1422
[Abstract][Full Text]
Lanzkron, S. M., Bell, W. R.
(1996). State-of-the-Art Review : Management of Patients Who Require Invasive Procedures Immediately Following Thrombolytic Therapy. CLIN APPL THROMB HEMOST
2: 158-163
[Abstract]
Shahak, A., Posan, E., Szucs, G., Rigo, J., Boda, Z.
(1996). Coumarin-Induced Skin Necrosis Following Heparin-Induced Thrombocytopenia and Thrombosis A Case Report. ANGIOLOGY
47: 725-727
[Abstract]
Topol, E. J., Nissen, S. E.
(1995). Our Preoccupation With Coronary Luminology : The Dissociation Between Clinical and Angiographic Findings in Ischemic Heart Disease. Circulation
92: 2333-2342
[Abstract][Full Text]
Lenderink, T., Simoons, M. L., Van Es, G.-A., Van de Werf, F., Verstraete, M., Arnold, A. E.R.
(1995). Benefit of Thrombolytic Therapy Is Sustained Throughout Five Years and Is Related to TIMI Perfusion Grade 3 But Not Grade 2 Flow at Discharge. Circulation
92: 1110-1116
[Abstract][Full Text]
Lee, K. L., Woodlief, L. H., Topol, E. J., Weaver, W. D., Betriu, A., Col, J., Simoons, M., Aylward, P., Van de Werf, F., Califf, R. M.
(1995). Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction : Results From an International Trial of 41 021 Patients. Circulation
91: 1659-1668
[Abstract][Full Text]
Leya, F., Fareed, J., Walenga, J.
(1995). Acute Myocardial Infarction: Diagnosis and Management. CLIN APPL THROMB HEMOST
1: 160-165
[Abstract]
Biemond, B. J., Levi, M., Coronel, R., Janse, M. J., Cate, J. W. t., Pannekoek, H.
(1995). Thrombolysis and Reocclusion in Experimental Jugular Vein and Coronary Artery Thrombosis : Effects of a Plasminogen Activator Inhibitor Type 1–Neutralizing Monoclonal Antibody. Circulation
91: 1175-1181
[Abstract][Full Text]
Grines, C. L., Topol, E. J., O'Neill, W. W., George, B. S., Kereiakes, D., Phillips, H. R., Leimberger, J. D., Woodlief, L. H., Califf, R. M.
(1995). Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction. Circulation
91: 298-303
[Abstract][Full Text]
Michels, K. B., Yusuf, S.
(1995). Does PTCA in Acute Myocardial Infarction Affect Mortality and Reinfarction Rates? : A Quantitative Overview (Meta-Analysis) of the Randomized Clinical Trials. Circulation
91: 476-485
[Abstract][Full Text]
Landau, C., Lange, R. A., Hillis, L. D.
(1994). Percutaneous Transluminal Coronary Angioplasty. NEJM
330: 981-993
[Full Text]
Chouhan, L., Hajar, H. A., George, T., Pomposiello, J. C.
(1993). Clinical and Angiographic Features of Patients with an Occluded Versus a Patent Infarct Vessel After Intravenous Streptokinase for Acute Myocardial Infarction. ANGIOLOGY
44: 425-431
[Abstract]
Grines, C. L., Browne, K. F., Marco, J., Rothbaum, D., Stone, G. W., O'Keefe, J., Overlie, P., Donohue, B., Chelliah, N., Timmis, G. C., Vlietstra, R. E., Strzelecki, M., Puchrowicz-Ochocki, S., O'Neill, W. W., The Primary Angioplasty in Myocardial Infarction S,
(1993). A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction. NEJM
328: 673-679
[Abstract][Full Text]
Lange, R. A., Hillis, L. D.
(1993). Immediate Angioplasty for Acute Myocardial Infarction. NEJM
328: 726-728
[Full Text]
Chouhan, L. K., Hajar, H. A., George, T., Pomposiello, J. C.
(1992). Clinical and Angiographic Features of Patients from the Indian Subcontinent Treated with Intravenous Streptokinase for Acute Myocardial Infarction: Experience in Qatar. ANGIOLOGY
43: 641-646
[Abstract]
Asonuma, H., Tanji, Y., Nakatoh, H., Nakajima, T., Akita, H., Sasaki, A., Shoji, K.
(1990). Successful Direct PTCA on LAD after First Episode of Acute Myocardial Infarction: Does It Improve Cardiac Function?. ANGIOLOGY
41: 724-730
[Abstract]
Haber, E, Quertermous, T, Matsueda, G., Runge, M.
(1989). Innovative approaches to plasminogen activator therapy. Science
243: 51-56
[Abstract]
Harris, E. J. JR, Porter, J. M.
(1989). Thrombolytic Therapy and Modern Vascular Surgery: An Overview. PERSPECT VASC SURG ENDOVASC THER
2: 40-63
(1987). ELECTIVE VERSUS EMERGENCY ANGIOPLASTY AFTER THROMBOLYTIC THERAPY. JWatch General
1987: 3-3
[Full Text]
Gibson, C. M., Cannon, C. P., Murphy, S. A., Marble, S. J., Barron, H. V., Braunwald, E., for the TIMI Study Group,
(2002). Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infarction. Circulation
105: 1909-1913
[Abstract][Full Text]
